Clinical and Experimental Ophthalmology · 2013 · 38 citations · 23 references
MedicineOphthalmologyPharmacologyOcular DiseaseOcular Drug DeliveryOcular PharmacologyCorneal Wound HealingDry Eye EvaluationOcular PharmacodynamicsTopical Ocular Drug DeliveryTopical Ophthalmic MedicationsCorneal ComplicationsCorneal EpithelializationDiabetic ComplicationsDry Eye EffectsNaltrexone TreatmentOcular Surface EffectsOcular Surface HypersensitivityOcular Surface Sensitivity
BACKGROUND: Ocular surface complications of type 2 diabetes are associated with reductions in tear production, increased corneal surface sensitivity, and delayed corneal re-epithelialization. This study examined the efficacy of topical application of the opioid antagonist naltrexone (NTX) in reversing these diabetic-related ocular surface complications in mice. METHODS: The genetic db/db mouse model of type 2 diabetes, along with C57Bl/6 wild-type mice were investigated. Tear production was assessed by phenol red impregnated threads, and ocular surface sensitivity was measured using Von Frey filaments. Centrally located, circular corneal abrasions were created in mice and residual epithelial defects measured by fluorescein photography. Animals in each group received topical applications of drops of 10(-5) M NTX in sterile Vigamox (Vigamox, Alcon Laboratories, Fort Worth, Texas, USA) or sterile Vigamox alone, and tear production, corneal sensitivity, and reepithelialization were monitored. RESULTS: In comparison to diabetic mice receiving vehicle only, db/db mice treated with one drop of NTX demonstrated a marked reversal in dry eye and ocular surface hypersensitivity within 1 h of one drop of NTX. Reversal of the complications in db/db mice usually lasted for 48-90 h. Corneal epithelial repair in db/db mice was enhanced following a regimen of three drops of NTX daily such that by 72 h, residual wounds were one third the size in db/db mice receiving NTX relative to diabetic mice receiving vehicle. Application of Vigamox alone had no effect. No adverse effects of NTX administration were noted in the cornea. CONCLUSIONS: This is the first report of the efficacy of topical NTX in reversing corneal surface complications in type 2 diabetic mice.
23
Corneal structure and sensitivity in type 1 diabetes mellitus.
M E Rosenberg, Timo Tervo, Ilkka Immonen et al. · PubMed · 2000 · 406 citations
Medicine, Neurology, Ophthalmology +17
Igor Kaiserman, Nadia Kaiserman, Sasson Nakar et al. · American Journal of Ophthalmology · 2005 · 202 citations
A mouse dry eye model induced by topical administration of benzalkonium chloride.
Zhirong Lin, Xiaochen Liu, Tong Zhou et al. · PubMed · 2011 · 169 citations · Full text
Medicine, Ophthalmology, Toxicology +17
Tear production and corneal sensitivity in diabetes
Pippa Cousen, Peter Cackett, Harry Bennett et al. · Journal of Diabetes and its Complications · 2007 · 141 citations